Mironid® extends Series A round raising £35 million to date for ...

Mironid® extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening ...

Mironid extends Series A round raising £35 million to date

Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening ...

Mironid extends Series A Funding; £35M Raised To Date - FinSMEs

The round, which brought the total amount raised to date to £35M, was led by Roche Venture Fund with participation from existing investors ...

Mironid - Sofinnova Partners

Mironid · Mironid® appoints Dr Catherine Kelleher as Chief Medical Officer · Mironid extends Series A round, raising £35 million to date for development of first- ...

Series A - Mironid - 2023-09-13 - Crunchbase Funding Round Profile

Overview · Organization Name. Mironid Logo. Mironid · Announced Date Sep 13, 2023 · Funding Type Series A · Funding Stage Early Stage Venture · Money Raised.

Pharma Industry News and Analysis | FirstWord Pharma

Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease.

Mironid Ltd. - Drug pipelines, Patents, Clinical trials - Patsnap Synapse

Mironid extends Series A round raising £35 million to date for development of first-. 100 Deals associated with Mironid Ltd. Login to view more data. 100 ...

Mironid reaches $43.7M to date in Series A extension to fund kidney ...

Mironid has raised a total of £35 million ($43.7 million) since its inception with the help of a Series A extension raise, setting it up to ...

Epidarex News – Page 3

Mironid Extends Series A Round Raising £35 Million to Date for Development of First-In-Class Small Molecules to Treat Life-Threatening Hereditary Kidney Disease.

University spin-out raises £35M to develop treatment for life ...

Mironid, a biopharmaceutical company spun out from the University of Strathclyde, has announced an extension of its Series A financing round.

Mironid - Updates, News, Events, Signals & Triggers - Crunchbase

Mironid may be growing as evidenced by the extension of its Series A funding round, with a total of £35 million raised to date. This significant capital ...

New Funding Rounds in "Chronic Inflammatory Diseases ...

Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney ...

Mironid company information, funding & investors | Dealroom.co

Recent News about Mironid · Healthcare Issue 37 Sep 11 – Sep 17, 2023 · Mironid extends Series A round raising £35 million to date for development of first-in- ...

Epidarex News – Page 4

Mironid Extends Series A Round Raising £35 Million to Date for Development ... Glasgow, Scotland – Mironid, a biopharmaceutical company developing ...

Mironid® Limited posted on the topic | LinkedIn

... Series A financing round, bringing the total amount raised since inception to £35 million. New…

Mironid advances finances for small molecule development

Mironid has raised $43.3 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney ...

New Funding Rounds in polycystic kidney disease - VentureRadar

Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease.

Global Drug Intelligence Database - Patsnap Synapse

Addex mGlu2 NAM Cognition Program Receives €4 Million Grant. Phase 2. 15 Sep 2023. ·www.globenewswire.com · Mironid extends Series A round raising £35 million ...

News feed - Estonia Innovation Ecosystem

San Francisco, United States. Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life ...

Mironid - Overview, News & Similar companies | ZoomInfo.com

Mironid has raised $6.2 Million in 1 funding round When was the last funding round for Mironid? Mironid closed its last funding round on Jun 19, 2016 with the ...